NCT04524702 2026-01-23Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic CancerEmory UniversityPhase 2 Completed10 enrolled 13 charts
NCT03519308 2024-03-15A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic CancerAbramson Cancer Center at Penn MedicinePhase EARLY_PHASE1 Terminated3 enrolled 13 charts